OVOL guides the epithelial-hybrid-mesenchymal transition.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 4558162)

Published in Oncotarget on June 20, 2015

Authors

Dongya Jia1,2, Mohit Kumar Jolly1,3, Marcelo Boareto1,4, Princy Parsana5, Steven M Mooney6,7, Kenneth J Pienta6,7,8,9, Herbert Levine1,3,10, Eshel Ben-Jacob1,11,12

Author Affiliations

1: Center for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA.
2: Graduate Program in Systems, Synthetic and Physical Biology, Rice University, Houston, TX 77005, USA.
3: Department of Bioengineering, Rice University, Houston, TX 77005, USA.
4: Institute of Physics, University of Sao Paulo, Sao Paulo 05508, Brazil.
5: Department of Computer Science, Johns Hopkins University, Baltimore, MD 21287, USA.
6: The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
7: Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
8: Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
9: Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
10: Department of Physics and Astronomy, Rice University, Houston, TX 77005, USA.
11: Department of Biosciences, Rice University, Houston, TX 77005, USA.
12: School of Physics and Astronomy and The Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv 69978, Israel.

Articles citing this

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol (2015) 1.15

Tumor Budding: The Name is EMT. Partial EMT. J Clin Med (2016) 1.00

Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget (2016) 0.99

Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget (2015) 0.86

An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States. PLoS Comput Biol (2015) 0.86

MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Oncotarget (2016) 0.80

Identification of Potentially Pathogenic Variants in the Posterior Polymorphous Corneal Dystrophy 1 Locus. PLoS One (2016) 0.79

Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis. Sci Rep (2015) 0.78

Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl (2016) 0.77

EMT and MET: necessary or permissive for metastasis? Mol Oncol (2017) 0.77

Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma. Onco Targets Ther (2016) 0.76

Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface (2016) 0.76

Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework. Oncotarget (2016) 0.75

Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells. Cell Cycle (2017) 0.75

Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity. Proc Natl Acad Sci U S A (2017) 0.75

Epithelial-mesenchymal plasticity: How have quantitative mathematical models helped improve our understanding? Mol Oncol (2017) 0.75

Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory. Cancers (Basel) (2017) 0.75

EMT: Present and future in clinical oncology. Mol Oncol (2017) 0.75

Articles cited by this

Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27

Cancer metastasis: building a framework. Cell (2006) 19.67

The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 11.16

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med (2003) 7.91

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell (2012) 5.53

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell (2012) 4.51

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014) 4.44

Cellular decision making and biological noise: from microbes to mammals. Cell (2011) 4.44

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010) 3.93

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res (2011) 3.25

Epithelial plasticity: a common theme in embryonic and cancer cells. Science (2013) 3.21

Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol (2011) 2.76

A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci U S A (2006) 2.60

Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol (2004) 2.53

ovo/svb integrates Wingless and DER pathways to control epidermis differentiation. Nature (1999) 2.32

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer (2011) 2.19

The ovo gene required for cuticle formation and oogenesis in flies is involved in hair formation and spermatogenesis in mice. Genes Dev (1998) 1.78

Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell (2007) 1.61

MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A (2013) 1.60

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis (2013) 1.49

Ovol1 regulates the growth arrest of embryonic epidermal progenitor cells and represses c-myc transcription. J Cell Biol (2006) 1.42

Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron (2011) 1.37

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle (2011) 1.34

Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One (2013) 1.32

Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene (2013) 1.32

EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev (2009) 1.25

SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Cell Stem Cell (2010) 1.21

Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. Cancer Res (2014) 1.20

Bacterial survival strategies suggest rethinking cancer cooperativity. Trends Microbiol (2012) 1.19

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene (2013) 1.19

Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle (2012) 1.18

Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance. Cancer Lett (2013) 1.18

The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. Genes Cancer (2010) 1.14

The mouse Ovol2 gene is required for cranial neural tube development. Dev Biol (2006) 1.11

Tristability in cancer-associated microRNA-TF chimera toggle switch. J Phys Chem B (2013) 1.10

Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res (2015) 1.07

Toward decoding the principles of cancer metastasis circuits. Cancer Res (2014) 1.05

Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. J R Soc Interface (2014) 1.04

Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells. Dev Cell (2014) 1.04

The zinc finger transcription factor Ovol2 acts downstream of the bone morphogenetic protein pathway to regulate the cell fate decision between neuroectoderm and mesendoderm. J Biol Chem (2013) 1.03

Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) (2010) 1.03

Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. Dev Cell (2014) 1.03

C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J Am Soc Nephrol (2009) 0.93

The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci Rep (2014) 0.92

Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proc Natl Acad Sci U S A (2015) 0.91

Ovol1 represses its own transcription by competing with transcription activator c-Myb and by recruiting histone deacetylase activity. Nucleic Acids Res (2007) 0.90

A control engineering approach to understanding the TGF-β paradox in cancer. J R Soc Interface (2011) 0.85

Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. PLoS One (2014) 0.84

A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression. BMC Syst Biol (2014) 0.81

Evidence for partial epithelial-to-mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev Dyn (2011) 0.81

Ovol proteins: guardians against EMT during epithelial differentiation. Dev Cell (2014) 0.79

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability. Front Cell Dev Biol (2014) 0.78